PDF(1430 KB)
PDF(1430 KB)
PDF(1430 KB)
1例新生儿常染色体显性智力障碍21型病例报告
Autosomal dominant intellectual disability type 21 in a neonate
1例1日龄男性新生儿因哭声弱1 d，反复唇周青紫2 h入院。患儿出生时有特殊面容，双手通贯掌，扁平足，哭声弱，喂养困难，合并先天性心脏病，头颅MRI异常。全外显子组测序分析显示CTCF基因第3外显子c.778_781delAAAG （p.Lys260ValfsTer2）新发突变，蛋白功能预测提示为致病突变，可能损害CTCF蛋白功能。结合患儿的临床表现和遗传分析结果，诊断为常染色体显性智力障碍21型。该病例提示，对于临床上有不明原因喂养困难，不能用感染、缺氧等原因进行解释的新生儿，应尽早进行遗传学分析，以帮助早期诊断和遗传咨询。
This is a case report on a 1-day-old male neonate admitted due to a weak cry for 1 day and recurrent circumoral cyanosis for 2 hours. He had unusual facial features at birth, with a single transverse palmar crease on both hands, flat feet, weak cry, feeding difficulties, congenital heart disease, and abnormality on cerebral MRI. Whole exome sequencing showed a de novo mutation, c.778_781delAAAG(p.Lys260ValfsTer2), in exon 3 of the CTCF gene, which was considered a pathogenic mutation by protein function prediction and might damage the function of CTCF protein. He was diagnosed with autosomal dominant intellectual disability type 21 based on the clinical manifestations and genetic analysis results. This case suggests that genetic analysis should be performed as early as possible for neonates with feeding difficulties which cannot be explained by infection or hypoxia, so as to help with early diagnosis and genetic counselling.
常染色体显性智力障碍21型 / CTCF基因 / 新发突变 / 喂养困难 / 新生儿
Autosomal dominant intellectual disability type 21 / CTCF gene / De novo mutation / Feeding difficulty / Neonate
[1] Gregor A, Oti M, Kouwenhoven EN, et al. De novo mutations in the genome organizer CTCF cause intellectual disability[J]. Am J Hum Genet, 2013, 93(1):124-131.
[2] Konrad EDH, Nardini N, Caliebe A, et al. CTCF variants in 39 individuals with a variable neurodevelopmental disorder broaden the mutational and clinical spectrum[J]. Genet Med, 2019, 21(12):2723-2733.
[3] Chen F, Yuan HM, Wu WY, et al. Three additional de novo CTCF mutations in Chinese patients help to define an emerging neurodevelopmental disorder[J]. Am J Med Genet C Semin Med Genet, 2019, 181(2):218-225.
[4] Bastaki F, Nair P, Mohamed M, et al. Identification of a novel CTCF mutation responsible for syndromic intellectual disability-a case report[J]. BMC Med Genet, 2017, 18(1):68.
[5] Hori I, Kawamura R, Nakabayashi K, et al. CTCF deletion syndrome:clinical features and epigenetic delineation[J]. J Med Genet, 2017, 54(12):836-842.
[6] Meng LY, Pammi M, Saronwala A, et al. Use of exome sequencing for infants in intensive care units:ascertainment of severe single-gene disorders and effect on medical management[J]. JAMA Pediatr, 2017, 171(12):e173438.
[7] Willsey AJ, Fernandez TV, Yu DM, et al. De novo coding variants are strongly associated with tourette disorder[J]. Neuron, 2017, 94(3):486-499.e9.
[8] Retterer K, Juusola J, Cho MT, et al. Clinical application of whole-exome sequencing across clinical indications[J]. Genet Med, 2016, 18(7):696-704.
[9] Kim S, Yu NK, Kaang BK. CTCF as a multifunctional protein in genome regulation and gene expression[J]. Exp Mol Med, 2015, 47(6):e166.
[10] Klenova EM, Nicolas RH, Paterson HF, et al. CTCF, a conserved nuclear factor required for optimal transcriptional activity of the chicken c-myc gene, is an 11-Zn-finger protein differentially expressed in multiple forms[J]. Mol Cell Biol, 1993, 13(12):7612-7624.
[11] Vostrov AA, Quitschke WW. The zinc finger protein CTCF binds to the APBβ domain of the amyloid β-protein precursor promoter. Evidence for a role in transcriptional activation[J]. J Biol Chem, 1997, 272(52):33353-33359.
[12] Bell AC, West AG, Felsenfeld G. The protein CTCF is required for the enhancer blocking activity of vertebrate insulators[J]. Cell, 1999, 98(3):387-396.
[13] Bell AC, Felsenfeld G. Methylation of a CTCF-dependent boundary controls imprinted expression of the Igf2 gene[J]. Nature, 2000, 405(6785):482-485.
[14] Matsuzaki H, Kuramochi D, Okamura E, et al. Recapitulation of gametic DNA methylation and its post-fertilization maintenance with reassembled DNA elements at the mouse Igf2/H19 locus[J]. Epigenetics Chromatin, 2020, 13(1):2.
[15] Bergström R, Whitehead J, Kurukuti S, et al. CTCF regulates asynchronous replication of the imprinted H19/Igf2 domain[J]. Cell Cycle, 2007, 6(4):450-454.
[16] Shukla S, Kavak E, Gregory M, et al. CTCF-promoted RNA polymerase Ⅱ pausing links DNA methylation to splicing[J]. Nature, 2011, 479(7371):74-79.
[17] López Soto EJ, Lipscombe D. Cell-specific exon methylation and CTCF binding in neurons regulate calcium ion channel splicing and function[J]. Elife, 2020, 9:e54879.
[18] Kang H, Cho H, Sung GH, et al. CTCF regulates Kaposi's sarcoma-associated herpesvirus latency transcription by nucleosome displacement and RNA polymerase programming[J]. J Virol, 2013, 87(3):1789-1799.
[19] Saldaña-Meyer R, Rodriguez-Hernaez J, Escobar T, et al. RNA interactions are essential for CTCF-mediated genome organization[J]. Mol Cell, 2019, 76(3):412-422.e5.
